GlassScriptPhysician profile
Sarah Berger
NPI 1528445103
$307.82
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
See the full distribution for Pediatrics (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $159 · 2022: $149.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $65.55 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $46.96 | 2021 | |
| Cranial Technologies, INC | $35.63 | 2021-2022 | |
| Kaleo, INC. | $31.11 | 2021 | |
| Glaxosmithkline, LLC. | $30.60 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $17.87 | 2022 | |
| Neos Therapeutics, LP | $17.01 | 2022 | |
| Phadia US INC. | $15.50 | 2022 | |
| Corium, LLC | $15.05 | 2021 | |
| Adlon Therapeutics L.P. | $14.34 | 2021 | |
| Baudax Bio INC. | $11.04 | 2021 | |
| Genentech USA, INC. | $7.16 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Berger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.